Active, not recruitingPhase 3NCT05470816

Tranexamic Acid to Reduce Delirium After Gastrointestinal Surgery: the TRIGS-D Trial

Studying NON RARE IN EUROPE: Alzheimer disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Bayside Health
Principal Investigator
Paul S Myles, DSci
Monash University
Intervention
Tranexamic Acid 100Mg/ml Inj Vial 10ml(drug)
Enrollment
826 target
Eligibility
18-100 years · All sexes
Timeline
2022 – 2026

Study locations (1)

Collaborators

Monash University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05470816 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Alzheimer disease →

← Back to all trials